<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25879">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02769858</url>
  </required_header>
  <id_info>
    <org_study_id>G016030</org_study_id>
    <nct_id>NCT02769858</nct_id>
  </id_info>
  <brief_title>The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression</brief_title>
  <official_title>The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study aims to establish the feasibility of light therapy for postpartum
      depression delivered via Re-Timer, demonstrate its preliminary efficacy, and illuminate
      relationships between circadian shifts and mood changes using a novel, home-based circadian
      biomarker assessment paradigm (salivary dim light melatonin onset; DLMO).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Score of the Hamilton Depression Rating Scale-Seasonal Affective Version (SIGH-SAD) at 5 weeks</measure>
    <time_frame>After five weeks of light therapy</time_frame>
    <description>Clinician-rated depression symptom severity measure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Score of the Edinburgh Postnatal Depression Scale at 5 weeks</measure>
    <time_frame>After five weeks of light therapy</time_frame>
    <description>Self-report of depression symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Time of Dim Light Melatonin Onset at 5 weeks</measure>
    <time_frame>After five weeks of light therapy</time_frame>
    <description>Onset of melatonin in dim light conditions as measured in saliva</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Depression, Postpartum</condition>
  <arm_group>
    <arm_group_label>Light Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will use commercially-available light therapy glasses (Re-Timer) daily for 60 minutes for five weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Light therapy</intervention_name>
    <description>Light therapy glasses</description>
    <arm_group_label>Light Therapy</arm_group_label>
    <other_name>Re-Timer</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Within 6 months postpartum

          -  Meet DSM-V diagnostic criteria for MDD

          -  Score â‰¥ 20 on the Structured Interview Guide for the Hamilton Depression Rating
             Scale-Seasonal Affective Disorder version (SIGH-SAD).

        Exclusion Criteria:

          -  current diagnosis of bipolar disorder, posttraumatic stress disorder, schizophrenia
             or psychosis, dissociative disorders, eating disorder, obsessive-compulsive disorder,
             somatic symptom and related disorders, substance use disorder, panic disorder,
             agoraphobia per DSM-V

          -  past history of mania/hypomania,

          -  chronic medical conditions associated with depression (e.g., thyroid conditions)

          -  ocular or retinal pathology

          -  history of seizures or epilepsy

          -  color blindness

          -  Lupus

          -  currently taking an antibiotic, medication that contains hydrochlorothiazide, or
             isotretinoin (Accutane).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leslie Swanson, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 19, 2016</lastchanged_date>
  <firstreceived_date>May 10, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Leslie Swanson</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression, Postpartum</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
